Product Manager, Genomic Vision
JUN 10, 2021 7:00 AM PDT
Simplify complex genetic diseases by quantifying structural and copy number variants
Speaker
Event Date & Time
Date: June 10, 2021
Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST)
Abstract
Discover how to categorize small-to-large genetic modifications using molecular combing. Our Proprietary Genome Morse Code (GMC) technology from Genomic Vision enables you to physically map and comprehensively analyze altered genes. You will see ways to use molecular combing with GMC to diagnose repeat associated diseases such as FSHD using the FiberProbes® FSHD CE-IVD assay. Gaining insights into the mechanics of such genetic diseases using molecular combing FiberProbes® and GMC facilitates the development of more efficient disease-treatment protocols and improved outcomes.
Additionally, you will discover how visualizing structural and copy number variants using molecular combing lets you directly correlate the underlying mechanics of familial adult myoclonic epilepsy (FAME) and other genetic diseases. FAME molecular combing exposes the considerable variability in repeat-length expansion, supporting the existence of multiple expansion configurations and mosaicism.
Learning Objectives:
- Outline how proprietary Genome Morse Code (GMC) technology enables you to physically map and comprehensively analyze altered genes
- Interpret the mechanics of such genetic diseases using molecular combing FiberProbes® and GMC facilitates the development of more efficient disease-treatment protocols and improved outcomes
- June 3 - How molecular combing technology is transforming genomic research through visualizing DNA at the single-molecule level - Mark Lynch
- June 10 - Simplify complex genetic diseases by quantifying structural and copy number variants - Mario Avarello
- Genomic rearrangements and structural variations
-
- June 24 - Improved quantitative understanding of oncological replication kinetics using molecular combing - Mario Avarello
- DNA replication stress and drug efficacy
-
- July 1 - Quality control advancements in therapeutic genome editing and biomanufacturing - Dr. Imen Mestiri
- Therapeutic genome editing, Biomanufacturing
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...